Table 3

Hypertension process of care indicators

Free medicine distributionUsual medicine accessUnadjusted differenceAdjusted difference
BP measurements3 (4) (173)3 (5) (160)0.95 (0.74 to 1.22)0.99 (0.77 to 1.27)
p=0.67p=0.92
HbA1c measurements1 (1) (37)1 (1) (42)0.77 (0.49 to 1.22)0.83 (0.53 to 1.30)
p=0.27p=0.41
Lipid measurements1 (1) (36)1 (1) (37)0.85 (0.54 to 1.35)0.91 (0.57 to 1.46)
p=0.49p=0.70
Serum creatinine measurements1 (4) (78)2 (13) (110)0.62 (0.39 to 1.00)0.61 (0.38 to 0.97)
p=0.05p=0.04
Serum electrolyte measurements1 (3) (66)2 (11) (103)0.56 (0.34 to 0.93)0.59 (0.36 to 0.98)
p=0.02p=0.04
Primary care encounters5 (9) (287)6 (14) (302)0.83 (0.66 to 1.05)0.9 (0.71 to 1.10)
p=0.11p=0.25
Consultant encounters related to hypertension0 (0) (5)0 (0) (5)0.88 (0.13 to 6.10)0.59 (0.07 to 4.62)
p=0.89p=0.61
Missed primary care appointments0 (0) (14)0 (4) (44)0.28 (0.12 to 0.64)0.41 (0.18 to 0.90)
p=0.00p=0.03
Self-monitoring of BP21% (12/56)18% (9/49)1.21 (0.46 to 3.18)1.10 (0.38 to 3.17)
p=0.70p=0.86
Total number of encounters and manoeuvres (assign 0 or 1 for binary indicators; exclude missed appointments)12 (43) (694)16 (97) (768)0.79 (0.63 to 1.00)0.83 (0.67 to 1.04)
p=0.04p=0.10
  • Count indicators are reported as the mean number of measurements or encounters with the variance and the sum of all measurements or encounters. Binary indicators are reported as a proportion. Differences are adjusted for age, sex and site, and reported as OR or rate ratio with the 95% CI and p value.

  • BP, blood pressure; HbA1c, glycated haemoglobin.